Dieter Koeberle Selected Research

Neutropenia

1/2011

Phase I dose-finding study of vandetanib in combination with gemcitabine in locally advanced unresectable or metastatic pancreatic adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dieter Koeberle Research Topics

Disease

13	Neoplasms (Cancer) 01/2019 - 03/2005
4	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 01/2016
4	Breast Neoplasms (Breast Cancer) 01/2009 - 01/2006
3	Disease Progression 01/2019 - 01/2011
3	Pain (Aches) 01/2018 - 08/2008
3	Esophageal Neoplasms (Esophageal Cancer) 01/2010 - 11/2005
2	Carcinoma (Carcinomatosis) 11/2020 - 09/2007
2	Rectal Neoplasms (Rectal Cancer) 01/2018 - 01/2017
2	Adenocarcinoma 01/2011 - 08/2009
2	Deglutition Disorders (Dysphagia) 01/2010 - 08/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2008 - 06/2007
1	COVID-19 04/2022
1	Cholangiocarcinoma 11/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018
1	Proctitis 01/2018
1	Cancer Pain 01/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Lung Neoplasms (Lung Cancer) 10/2015
1	Adenocarcinoma of Lung 10/2015
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 06/2012
1	Aphasia (Dysphasia) 01/2011
1	Neutropenia 01/2011
1	Hepatocellular Carcinoma (Hepatoma) 01/2010
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 08/2008
1	Neoplasm Metastasis (Metastasis) 01/2007
1	Hemangioblastoma 03/2005
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2005
1	Cysts 03/2005
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 03/2005
1	Pheochromocytoma 03/2005
1	Cystadenoma 03/2005
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2005

Drug/Important Bio-Agent (IBA)

6	Capecitabine (Xeloda)FDA Link 01/2019 - 06/2007
5	Gemcitabine FDA Link 11/2020 - 06/2007
3	Bevacizumab (Avastin)FDA Link 06/2021 - 12/2016
3	Aromatase InhibitorsIBA 01/2007 - 01/2006
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 06/2012
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 06/2012
2	Analgesics (Analgesic Drugs)IBA 08/2008 - 08/2008
2	Letrozole (Femara)FDA LinkGeneric 01/2007 - 01/2006
2	Hormones (Hormone)IBA 01/2007 - 01/2006
2	Tamoxifen FDA LinkGeneric 01/2007 - 01/2007
1	Oxygen (Dioxygen)IBA 04/2022
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	AntibodiesIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	IpilimumabIBA 01/2016
1	Immune Checkpoint InhibitorsIBA 01/2016
1	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2016
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 06/2012
1	Cladribine FDA LinkGeneric 06/2012
1	vandetanib (ZD6474)IBA 01/2011
1	EnzymesIBA 01/2011
1	Sunitinib (Sutent)FDA Link 01/2010
1	Morphine (MS Contin)FDA LinkGeneric 08/2008
1	A 19IBA 01/2007
1	Estrogens (Estrogen)FDA Link 01/2006
1	Retinaldehyde (Retinal)IBA 03/2005
1	BPH-associated protein P25-26IBA 03/2005

Therapy/Procedure

9	Therapeutics 06/2021 - 01/2006
5	Drug Therapy (Chemotherapy) 12/2016 - 11/2005
3	Radiotherapy 01/2018 - 10/2013
2	Neoadjuvant Therapy 01/2018 - 08/2009
2	Induction Chemotherapy 01/2010 - 08/2009
1	Immunotherapy 01/2016
1	Esophagectomy 08/2009